Detalles de la búsqueda
1.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880613
2.
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
Am J Hematol
; 93(11): 1394-1401, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30132965
3.
Prolonged Remission of Prostate Cancer Presenting as Endobronchial Metastases Following Total Androgen Blockade: A Case Report and Literature Review.
Case Rep Oncol
; 12(3): 715-720, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31607889
4.
Analysis of Efficacy and Tolerability of Bruton Tyrosine Kinase Inhibitor Ibrutinib in Various B-cell Malignancies in the General Community: A Single-center Experience.
Clin Lymphoma Myeloma Leuk
; 17S: S53-S61, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760303
5.
Immunoglobulin D Multiple Myeloma, Plasma Cell Leukemia and Chronic Myelogenous Leukemia in a Single Patient Treated Simultaneously with Lenalidomide, Bortezomib, Dexamethasone and Imatinib.
Hematol Rep
; 8(1): 6295, 2016 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27103978
6.
Coagulopathy and functional hyposplenism during an episode of thrombotic thrombocytopenic purpura in a HgbS/ß (+)-thalassemia patient.
Clin Case Rep
; 3(7): 521-6, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26273433
7.
Bulky scalp melanoma with metastasis responding completely to ipilimumab.
BMJ Case Rep
; 20162016 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27298296
Resultados
1 -
7
de 7
1
Próxima >
>>